Joshua Byrini's Market View
Byrini's obeservations should not be considered recommendations, advice or suggestions to buy, sell or hold securities, commodities, commodity contracts, options, futures, warrants, insurance contracts, real estate, gemstones, art work or derivatives, as he is neither a registered securities, commodities or real estate broker, diamond merchant, art dealer, or investment advisor. These observations are for informational purposes only. In other words, you are on your own chief.Tuesday, October 11, 2005
Bird Flu Plays...
Gilead (GILD) invented Tamiflu, the popular antiviral drug, but licensed it to Roche Holding Ltd. in 1996 (RHHBY).
Between 2001 and 2004, Tamiflu's annual sales were $200 million, which earned Gilead royalties of between 7% and 11%.
But fear of the Avian flu and a possible pandemic has prompted 30 governments, including that of the U.S., to stockpile the drug.
Gilead has launched a legal battle to wrest control of Tamiflu from Roche. If it's successful, that would be a major coup: Citigroup's Werber projects Tamiflu's sales will reach $850 million in 2005.
posted by BoxedMerlot # 11:26 PM 
Archives
October 2005 November 2005 December 2005 January 2006 March 2009
